Lymphedema Treatment Market

Lymphedema Treatment Market - An Overview

The global lymphedema treatment market is expected to witness slow growth during the forecast period between 2021 and 2031.

Lymphedema is a disease, characterized by an abnormal enlargement in the human body, owing to a damaged lymphatic system. Lymphedema usually occurs in the upper extremities of the human body. In some cases, it could occur in women, who have undergone treatment for breast cancer.

Lymphedema can reportedly occur within days, following breast cancer treatment. The disease has no permanent cure and can affect a person for the entire lifetime.

Lymphedema can be primary and secondary. Primary lymphedema is often present from birth, while secondary lymphedema occurs owing to impairment in the lymphatic system.

Lymphedema Treatment Market - Trends and Opportunities

Rising prevalence of lymphedema and breast cancer diseases globally are the key growth drivers for the lymphedema treatment market. As per the World Cancer Research Fund, approximately 2 million cases of breast cancer were reported worldwide in 2018.

In addition to this, the launch of novel products for lymphedema treatment is expected to help fuel the growth in the overall lymphedema treatment market, in the coming years.

Also, technological advancements to lymphedema treatment methods is anticipated to propel the lymphedema treatment market, in future.

Government initiatives and measures to promote lymphedema treatment and investments from private investors could also have a positive effect on the growth of the lymphedema treatment market, in the upcoming years.

The compression therapy treatment segment is anticipated to make the largest contribution to the overall growth of the lymphedema treatment market in the coming years, as it has helped manage the lymphedema symptoms more effectively than any other treatment method.

In terms of end-use, the hospital segment is expected to provide lucrative growth opportunities for the lymphedema treatment market, in the next few years.

Lymphedema Treatment Market - Competitive Landscape

The global lymphedema market comprises very few players, many of whom could engage in different growth strategies, which could help them remain maintain their foothold in the overall market.

The smaller players in the lymphedema market would seek investments from private investors in a bid to grow and overtake some of their competitors in the global lymphedema treatment market.

R&D activities could be a key growth strategy for the lymphedema treatment market players, in the coming years.

Some of the key players in the lymphedema treatment market include BSN Medical, Tactile Medical, and Lohmann and Raucher GmbH.

Lymphedema Treatment Market - Regional Assessment

The global lymphedema treatment market is classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.

North America is expected to be the leader in the lymphedema treatment market in the coming years owing to the rising prevalence of lymphedema in countries such as the U.S and Canada, which is attributed to the increased presence of breast cancer, in these countries.

The presence of some large players in lymphedema treatment market in the U.S and Canada is also expected to positively impact the lymphedema treatment market, in this region.

Europe is expected to stand second behind North America in the lymphedema treatment market, owing to the development of novel treatment products and collaborations in countries such as U.K and Germany.

Asia Pacific is expected to witness slow growth in the lymphedema treatment market due to the developing healthcare infrastructure facilities such as India.

Prominent market players could look to establish R&D centers in Asia Pacific countries, which could help in the growth of the lymphedema market, in the region.

Other regions such as Middle East and Africa and Latin America are expected to witness moderate growth in the lymphedema treatment market, in the coming years.